Expertise in
2
conditions

Veronique Danel

Lille, FR 
Expertise in
2
conditions
Lille, FR 

Overview

Veronique Danel practices practicing medicine in Lille, France.

Ms. Danel is highly rated in 2 conditions, according to our data. Her clinical expertise encompasses Primary Lateral Sclerosis and Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease).

She is actively involved in clinical research, co-authoring 11 peer reviewed articles and participating in 2 clinical trials.

Gender

Female

Locations

Lille, France
Other Locations
Tours, France
Montpellier, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Efficacy and Safety of Low-dose IL-2 (Ld-IL-2) as a Treg Enhancer for Controlling Neuro-inflammation in Newly Diagnosed Amyotrophic Lateral Sclerosis (ALS) Patients: A Randomized, Double-blind, Placebo- Controlled, Phase-II Proof of Concept/ Proof of Mechanism Clinical Trial
Efficacy and Safety of Low-dose IL-2 (Ld-IL-2) as a Treg Enhancer for Controlling Neuro-inflammation in Newly Diagnosed Amyotrophic Lateral Sclerosis (ALS) Patients: A Randomized, Double-blind, Placebo- Controlled, Phase-II Proof of Concept/ Proof of Mechanism Clinical Trial
Enrollment Status: Completed
Publish Date: December 04, 2025
Intervention Type: Drug
Study Drugs: Riluzole, IL-2
Study Phase: Phase 2
Evaluation of Metabolomic Analysis in Early Diagnosis of ALS
Evaluation of Metabolomic Analysis in Early Diagnosis of ALS
Enrollment Status: Completed
Publish Date: July 17, 2019
Intervention Type: Procedure
Study Phase: Not Applicable
View 1 Less Clinical Trial

11 Total Publications

Tofersen Treatment in SOD1-ALS: Real-World Evidence from a Retrospective Multicenter Study in France (FORSLA Study).
Tofersen Treatment in SOD1-ALS: Real-World Evidence from a Retrospective Multicenter Study in France (FORSLA Study).
Journal: Mayo Clinic proceedings. Innovations, quality & outcomes
Published: August 04, 2026

Frequently Asked Questions about Veronique Danel

Is Veronique Danel a top-rated expert for Primary Lateral Sclerosis?

MediFind is an objective health platform that identifies experts based on real-world data. Veronique Danel is classified as an Advanced expert for Primary Lateral Sclerosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Veronique Danel participate in research or clinical trials?

Yes. Veronique Danel has published 11 articles and abstracts on conditions like Primary Lateral Sclerosis. You can view a list of Veronique Danel's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Danel's expertise for a condition
ConditionClose
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile